CPDR SATURDAY DISTINGUISHED VISITING PROFESSOR
Dr. Fritz H. Schröder
Professor of Urology
Erasmus Medical Center
Rotterdam, the Netherlands
International Co-ordinator of the European Randomized Study
of Screening for Prostate Cancer (ERSPC)
Topic: "Screening for Prostate Cancer - How to Advise in a Situation of Uncertainty?"
DATE: December 1, 2012
CONTINENTAL BREAKFAST: 8:15-9:00 am
LECTURE: 9:00-10:15 am
RSVP: Please register via the event website: CPDR Schröder
by Friday, November 16, 2012
Uniformed Services University
Building B, Sanford Auditorium
4301 Jones Bridge Road, Bethesda, MD
*Venue location tentative based on response
*Please access post via the Metro Gate on Wisconsin Ave.
Doctor Fritz H. Schröder studied Medicine in Hamburg, Marburg, and at the University of Saarbrücken. He completed his Urological training in Hamburg/Saar and at the University of California in Los Angeles in 1971. From 1969 through 1970, he completed a research fellowship at the Department of Biology, University of California, San Diego. His PhD thesis (Habilitation) was completed in 1972, and was titled, "Endocrinological and Morphological Studies of Prostatic Tumors in vitro." From 1972 through 1976, Dr. Schröder was Associate Professor of Urology at the University of Würzburg. From 1977 through 2002, Dr. Schröder chaired the Department of Urology, Erasmus University and Academic Hospital Rotterdam, the Netherlands. Professor Schröder serves as the international coordinator of the European Randomized study of Screening for Prostate Cancer.
Professor Schröder is author and co-author of more than 650 peer-reviewed publications, 197 book chapters, and is the editor of 21 monographs. He is the recipient of numerous research grants in the United States, Germany, the Netherlands, and throughout Europe. His research activities concentrate on clinical and experimental aspects of urologic oncology.
2018 AACR Annual Meeting
Chicago, Illinois April 14-18, 2018
The 2018 AACR Annual Meeting gathered this year at McCormick Place, Chicago, Illinois from April 14 to 18 under the theme of Driving Innovative Cancer Science to Patient Care. The Center for Prostate Disease Research (CPDR) multi-disciplinary team - together with collaborators – delivered one podium presentation and 12 poster presentations. The team was co-led by Dr. Shiv Srivastava, CPDR Co-Director and Professor, and Dr. Albert Dobi, Associate Director, CPDR and Research Assistant Professor, of the Department of Surgery, USU and WRNMMC.
Read the March 2019 CPDR E-Newsletter
ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development
Scientific Reports | 7: 1109 | DOI:10.1038/s41598-017-01187-4
Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells
Mol Cancer Res. 2017 Oct;15(10):1308-1317. doi: 10.1158/1541-7786.MCR-17-0058. Epub 2017 Jun 12.
Ethnicity and ERG Frequency in Prostate Cancer
Nat Rev Urol. 2017 Sep 5. doi: 10.1038/nrurol.2017.140. [Epub ahead of print]